|
|||||||||||||||||||||||||||||||||||||||||
Did you know there are more than 300,000 insulin pump users in the United States? Find out what you need to know to provide safe and optimum care to a patient with an insulin pump by reading PATIENT SAFETY: Assessing a Patient with an Insulin Pump. Browse our Recommended Readings on caffeinated energy drinks, the state of breastfeeding in the U.S., procedural violations in healthcare, and more. |
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
The FDA has granted orphan drug designation to Bosulif (bosutinib) tablets for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia with resistance or intolerance to prior therapy, including imatinib. |
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
Email this NursingCenter eNews to your colleagues and invite them to join now. They, too, will receive great content as well as free articles and discount offers available only to subscribers. Want to make sure that you keep receiving NursingCenter eNews? Be sure to add [email protected] to your address book! NursingCenter respects your privacy and will not share your information with other companies or organizations without your permission. View our Privacy Policy. If you no long wish to receive NursingCenter eNews, click on the "Unsubscribe" link above. Forgotten your username or password? Please contact Customer Service at [email protected]. http://www.nursingcenter.com |
---|